Abstract
<ns4:p>Alzheimer’s disease is the most common cause of dementia worldwide, with the prevalence continuing to grow in part because of the aging world population. This neurodegenerative disease process is characterized classically by two hallmark pathologies: β-amyloid plaque deposition and neurofibrillary tangles of hyperphosphorylated tau. Diagnosis is based upon clinical presentation fulfilling several criteria as well as fluid and imaging biomarkers. Treatment is currently targeted toward symptomatic therapy, although trials are underway that aim to reduce the production and overall burden of pathology within the brain. Here, we discuss recent advances in our understanding of the clinical evaluation and treatment of Alzheimer’s disease, with updates regarding clinical trials still in progress.</ns4:p>
Keywords
MedicineDiseaseClinical trialDementiaPathologyNeuroscienceOpen peer reviewPopulationIntensive care medicineBioinformaticsPlant biologyBiology
Affiliated Institutions
Related Publications
Alzheimer Disease: An Update on Pathobiology and Treatment Strategies
Alzheimer disease (AD) is a heterogeneous disease with a complex pathobiology. The presence of extracellular β-amyloid deposition as neuritic plaques and intracellular acc...
Tau is essential to β-amyloid-induced neurotoxicity
Senile plaques and neurofibrillary tangles, the two hallmark lesions of Alzheimer's disease, are the results of the pathological deposition of proteins normally present througho...
Enhanced Neurofibrillary Degeneration in Transgenic Mice Expressing Mutant Tau and APP
JNPL3 transgenic mice expressing a mutant tau protein, which develop neurofibrillary tangles and progressive motor disturbance, were crossed with Tg2576 transgenic mice expressi...
Early Clinical PET Imaging Results with the Novel PHF-Tau Radioligand [F-18]-T807
Aggregates of hyperphosphorylated tau (PHF-tau), such as neurofibrillary tangles, are linked to the degree of cognitive impairment in Alzheimer's disease. We have developed a no...
Early Alzheimer's disease genetics
The genetics community working on Alzheimer's disease and related dementias has made remarkable progress in the past 20 years. The cumulative efforts by multiple groups have lea...
Publication Info
- Year
- 2018
- Type
- preprint
- Volume
- 7
- Pages
- 1161-1161
- Citations
- 1012
- Access
- Closed
External Links
Social Impact
Altmetric
PlumX Metrics
Social media, news, blog, policy document mentions
Citation Metrics
1012
OpenAlex
Cite This
Jason Weller,
Andrew E. Budson
(2018).
Current understanding of Alzheimer’s disease diagnosis and treatment.
F1000Research
, 7
, 1161-1161.
https://doi.org/10.12688/f1000research.14506.1
Identifiers
- DOI
- 10.12688/f1000research.14506.1